Laatste proeven

EudraCT Number: 2006-000606-23

Sponsor Protocol Number: 26756

Start Date: 2006-11-23

Sponsor Name: Merck, S.L.

Full Title: Post-authorization safety study to check the potential association between the safety profile of beta interferon 1a and the body mass index or pharmacodynamics during the titration phase

Medical condition: Not applicalbe

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.1	10029205 - Nervous system disorders	10028245	Multiple sclerosis	PT

Population Age: Adults

Gender: Male, Female

Trial protocol: ES (Completed)

Trial results: View results

EudraCT Number: 2006-003512-22

Sponsor Protocol Number: 0869-130

Start Date: 2006-11-23

Sponsor Name: Laboratoires Merck Sharp & Dohme-Chibret

Full Title: A Randomized, Double-Blind, Parallel-Group Study Conducted Under In-House Blinding Conditions to Determine the Efficacy and Tolerability of Aprepitant for the Prevention of Chemotherapy-Induced Nau...

Medical condition: Chemotherapy-induced Nausea and Vomitting

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Completed) DE (Completed)

Trial results: View results

EudraCT Number: 2005-003819-71

Sponsor Protocol Number: DX-88/14

Start Date: 2006-11-23

Sponsor Name: Dyax Corp

Full Title: EDEMA3: Evaluation of DX-88’s Effects in Mitigating Angioedema A double-blind, placebo-controlled study followed by a repeat dosing phase to assess the efficacy and safety of DX-88 (recombinant pl...

Medical condition: Hereditary Angioedema

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Children, Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: BE (Completed) GB (Completed) IT (Completed)

Trial results: (No results available)

EudraCT Number: 2006-001595-20

Sponsor Protocol Number: CRAD001J2102

Start Date: 2006-11-23

Sponsor Name: NOVARTIS FARMA

Full Title: A phase Ib study investigating the combination of RAD001 with trastuzumab and vinorelbine in patients with HER2- overexpressing metastatic breast cancer

Medical condition: HER2 overexpressing metastatic breast cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10021977	Inflammatory carcinoma of breast recurrent	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: View results

EudraCT Number: 2006-002335-24

Sponsor Protocol Number: 13362B

Start Date: 2006-11-23

Sponsor Name: University of Chicago

Full Title: A Phase III Randomized Trial of Docetaxel Based Induction Chemotherapy in Patients with N2/N3 Locally Advanced Head and Neck Cancer Estudio de fase III randomizado de una quimioterapia de inducción...

Medical condition: Phase III trial of induction therapy with docetaxel followed by chemoradiotherapy versus chemoradiotherapy alone in patients with nodal stage N2 or N3 head and neck cancer

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2006-005494-21

Sponsor Protocol Number: MARIA

Start Date: 2006-11-23

Sponsor Name: HYKS Marian sairaala

Full Title: Hyperbaarisen artikaiini-glukoosiliuoksen ja pelkän artikaiinin vertailu spinaalipuudutuksessa nivustyräpotilailla

Medical condition: nivustyrä

Disease:	Version	SOC Term	Classification Code	Term	Level
	8.1		10019909	Hernia	LLT

Population Age: Adults

Gender: Male, Female

Trial protocol: FI (Completed)

Trial results: (No results available)

EudraCT Number: 2006-005127-42

Sponsor Protocol Number: APIDR_L_01896

Start Date: 2006-11-22

Sponsor Name: Institut für Klinische Forschung und Entwicklung (ikfe) GmbH

Full Title: Effect of Prandial Treatment with Insulin Glulisine compared to Regular Human Insulin on Postprandial Endothelial Function and Microvascular Stress in Type 2 Diabetic Patients

Medical condition: Diabetes mellitus Type 2

Disease:	Version	SOC Term	Classification Code	Term	Level
	8.1		10012601	Diabetes mellitus	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: (No results available)

EudraCT Number: 2005-003632-22

Sponsor Protocol Number: WA19078

Start Date: 2006-11-22

Sponsor Name: F. Hoffmann-La Roche Ltd.

Full Title: An open-label, exploratory study of the pharmacokinetic and pharmacodynamic activity of rituximab in combination with methotrexate (MTX) in synovial tissue and in peripheral blood of patients with ...

Medical condition: Rheumatoid arthritis

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Completed)

Trial results: View results

EudraCT Number: 2006-002679-42

Sponsor Protocol Number: SNT-II-003

Start Date: 2006-11-22

Sponsor Name: Santhera Pharmaceuticals (Switzerland) Limited

Full Title: A double blind, randomised, placebo-controlled study of the efficacy, safety and tolerability of idebenone in the treatment of patients with Leber's Hereditary Optic Neuropathy

Medical condition: Leber's Hereditary Optic Neuropathy

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: GB (Completed) DE (Completed)

Trial results: View results

EudraCT Number: 2006-000679-14

Sponsor Protocol Number: Mio/Reg/percutáneo/Aleatorizado

Start Date: 2006-11-22

Sponsor Name: INSTITUTO CIENTÍFICO Y TECNOLÓGICO (ICT )DE NAVARRA, S.A.

Full Title: ESTUDIO DE FASE II CIEGO, CONTROLADO Y ALEATORIZADO DE EFICACIA DEL IMPLANTE PERCUTÁNEO DE MIOBLASTOS AUTÓLOGOS EN PACIENTES CON INFARTO ANTIGUO. (STUDY PHASE II BLINDED, CONTROLATED AND RANDOMIZED...

Medical condition: PACIENTES CON INFARTO ANTIGUO DE MIOCARDIO (PATIENTS WITH OLD MYOCARDIAL INFARCT)

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10052475		PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Completed)

Trial results: View results

Laatste proeven

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies